Aminoglycosides use has a risk of acute kidney injury in patients without prior chronic kidney disease
Open Access
- 14 October 2022
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-9
Abstract
The outcome of acute kidney injury (AKI) as a result of aminoglycosides (AGs) use remains uncertain in patients without prior chronic kidney disease (CKD). Therefore, we explored the outcomes of AGs use on AKI episodes associated with renal recovery and progress in patients without prior CKD in Taiwan. This was a retrospective cohort study by using the Taipei Medical University Research Database from January 2008 to December 2019. 43,259 individuals without CKD who had received parenteral AGs were enrolled. The exposed and unexposed groups underwent propensity score matching for age, gender, patients in intensive care unit/emergency admission, and covariates, except serum hemoglobin and albumin levels. We identified an exposed group of 40,547 patients who used AGs (median age, 54.4 years; 44.3% male) and an unexposed group of 40,547 patients without AG use (median age, 55.7 years; 45.5% male). There was the risk for AKI stage 1 (adjusted hazard ratio [HR] 1.34; 95% confidence interval [CI] 1.00–1.79; p = 0.05) in patients that used AGs in comparison with the control subjects. Moreover, patients using AGs were significantly associated neither with the progression to acute kidney disease (AKD) stages nor with the progression to end-stage renal disease (ESRD) on dialysis. Further analyzed, there was an increased risk of AKI episodes for serum albumin levels less than 3.0 g/dL and hemoglobin levels less than 11.6 g/dL. Among patients without prior CKD, AGs-used individuals were associated with AKI risks, especially those at relatively low albumin (< 3.0 g/dL) or low hemoglobin (< 11.6 g/dL). That could raise awareness of AGs prescription in those patients in clinical practice.Keywords
Funding Information
- Taipei Medical University (TMU108-AE1-B23)
This publication has 46 references indexed in Scilit:
- Trends in Aminoglycoside Use and Gentamicin-Resistant Gram-Negative Clinical Isolates in US Academic Medical Centers: Implications for Antimicrobial StewardshipInfection Control & Hospital Epidemiology, 2012
- New insights into the mechanism of aminoglycoside nephrotoxicity: an integrative point of viewKidney International, 2011
- Gentamicin-associated acute kidney injuryQJM: An International Journal of Medicine, 2009
- Glomerular nephrotoxicity of aminoglycosidesToxicology and Applied Pharmacology, 2007
- Hypoalbuminemia in Acute Illness: Is There a Rationale for Intervention?Annals of Surgery, 2003
- Design issues for drug epidemiologyBritish Journal of Clinical Pharmacology, 2000
- Incidence of and Significant Risk Factors for Aminoglycoside-Associated Nephrotoxicity in Patients Dosed by Using Individualized Pharmacokinetic MonitoringThe Journal of Infectious Diseases, 1993
- Impact of dosage schedule of antibiotics on the treatment of serious infectionsIntensive Care Medicine, 1990
- Is the randomized controlled trial the real paradigm in epidemiology?Journal of Chronic Diseases, 1986
- Mechanism of Reduced Glomerular Filtration Rate in Chronic MalnutritionJournal of Clinical Investigation, 1980